Comprehensive mutation profiling by next‐generation sequencing of effusion fluids from patients with high‐grade serous ovarian carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1934-6638|123|5|289-297

ISSN： 1934-662x

Source： CANCER CYTOPATHOLOGY, Vol.123, Iss.5, 2015-05, pp. : 289-297

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The prognostic value of perioperative, pre‐systemic therapy CA125 levels in patients with high‐grade serous ovarian cancer

By  

International Federation of Gynecology and Obstetrics, Vol. 140, Iss. 2, 2018-02 ,pp. : 247-252

John Wiley & Sons Inc

Access to resources Recommend Favorite

Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high‐grade serous carcinoma

By  

APMIS (ELECTRONIC), Vol. 126, Iss. 1, 2018-01 ,pp. : 45-55

John Wiley & Sons Inc

Access to resources Recommend Favorite

High-Grade Serous Tumor Arising from Fallopian Tube in a BRCA Mutation Carrier after Prophylactic Oophorectomy

By  

Case Reports in Oncology, Vol. 6, Iss. 1, 2013-01 ,pp. : 21-24

Karger

Access to resources Recommend Favorite

Efficient molecular subtype classification of high‐grade serous ovarian cancer

By  

THE JOURNAL OF PATHOLOGY, Vol. 236, Iss. 3, 2015-07 ,pp. : 272-277

John Wiley & Sons Inc

Access to resources Recommend Favorite

Next‐generation sequencing: comprehensive genetic testing for epidermolysis bullosa

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 7-0963, Iss. 3, 2015-09 ,pp. : 638-639

John Wiley & Sons Inc

Access to resources Recommend Favorite